Cell-associated HIV RNA and the ratio of HIV RNA to DNA have circadian cycles in HIV-positive individuals on antiretoviral therapy

• J. Stern,
• M. Roche,
• A. Solomon,
• A. Dantanarayana,
• A. Reynaldi,
• M. Davenport,
• S.G. Deeks,
• W. Hartogenesis,
• F.M. Hecht,
• L. Cockerham,
• S.R. Lewin

Affiliations

J. Stern

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

M. Roche

RMIT University, School of Health and Biomedical Science, Melbourne, Australia

A. Solomon

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

A. Dantanarayana

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

A. Reynaldi

Kirby Institute, University of New South Wales, Sydney, Australia

M. Davenport

Kirby Institute, University of New South Wales, Sydney, Australia

S.G. Deeks

University of California San Francisco, Department of Medicine, San Francisco, CA, USA

W. Hartogenesis

Osher Center for Integrative Medicine, University of California San Francisco, San Francisco, CA, USA

F.M. Hecht

Osher Center for Integrative Medicine, University of California San Francisco, San Francisco, CA, USA

L. Cockerham

Division of Infectious Diseases, Medical College of Wisconsin, Milwaukee, WI, USA

S.R. Lewin

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia; Alfred Hospital and Monash University, Department of Infectious Diseases, Melbourne, Australia